Pulmonary Function Study Assessments

Published on 23/05/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1763 times

Pulmonary Function Study Assessments

Chapter Objectives

After reading this chapter, you will be able to:

• Describe the following lung volumes and capacities:

• Tidal volume (VT)

• Inspiratory reserve volume (IRV)

• Expiratory reserve volume (ERV)

• Residual volume (RV)

• Vital capacity (VC)

• Inspiratory capacity (IC)

• Functional residual capacity (FRC)

• Total lung capacity (TLC)

• Residual volume/total lung capacity ratio (RV/TLC)

• List the normal lung volumes and capacities of normal recumbent subjects who are 20 to 30 years of age.

• Identify lung volumes and capacity findings characteristic of restrictive lung disorders.

• Describe the anatomic alterations of the lungs associated with restrictive lung disorders.

• Identify lung volumes and capacity findings characteristic of obstructive lung disorders.

• Describe the anatomic alterations of the lungs associated with obstructive lung disorders.

• List the indirect measurements of the residual volume and lung capacities containing the residual volume.

• Describe expiratory flow rate and volume measurements and their respective normal values:

• Forced vital capacity (FVC)

• Forced expiratory volume timed (FEVT)

• Forced expiratory volume in 1 second/forced vital capacity ratio (FEV1/FVC)

• Forced expiratory flow at 25% to 75% (FEF25%-75%)

• Forced expiratory flow at 50% (FEF50%)

• Forced expiratory flow between 200 and 1200 mL of FVC (FEF200-1200)

• Peak expiratory flow rate (PEFR)

• Maximum voluntary ventilation (MVV)

• Flow-volume loop

• Describe how the FVC, FEV1, and FEV1/FVC are used to differentiate restrictive and obstructive lung disorders.

• Identify forced expiratory flow rate findings characteristic of restrictive lung disorders.

• Identify forced expiratory flow rate findings characteristic of obstructive lung disorders.

• Describe the pulmonary diffusion capacity (Dlco).

• Identify Dlco findings characteristic of restrictive lung disorders.

• Identify Dlco findings characteristic of obstructive lung disorders.

• Define key terms and complete self-assessment questions at the end of the chapter and on Evolve.

Pulmonary function studies play a major role in the assessment of pulmonary disease. The results of pulmonary function studies are used to (1) evaluate pulmonary causes of dyspnea, (2) differentiate between obstructive and restrictive pulmonary disorders, (3) assess severity of the pathophysiologic impairment, (4) follow the course of a particular disease, (5) evaluate the effectiveness of therapy, and (6) assess the patient’s preoperative status. Pulmonary function studies are commonly subdivided into the following three categories: (1) lung volumes and lung capacities, (2) forced expiratory flow rate and volume measurements, and (3) pulmonary diffusion capacity measurements.

Normal Lung Volumes and Capacities

As shown in Table 3-1, gas in the lungs is divided into four lung volumes and four lung capacities. The lung capacities represent different combinations of lung volumes. The amount of air the lungs can accommodate varies with age, weight, height, gender, and, to a much lesser extent, race. Prediction formulas for normal values exist that take these variables into account. Lung volumes and capacities change as a result of pulmonary disorders. These changes are classified as either restrictive lung disorders or obstructive lung disorders.

Table 3-1

Lung Volumes and Capacities of Normal Recumbent Subjects 20 to 30 Years of Age

  Male (in milliliters) Female (in milliliters)
Lung Volume Measurements    
Tidal volume (VT): The volume of gas that normally moves into and out of the lungs in one quiet breath. 500 400-500
Inspiratory reserve volume (IRV): The volume of air that can be forcefully inspired after a normal tidal volume. 3100 1900
Expiratory reserve volume (ERV): The volume of air that can be forcefully exhaled after a normal tidal volume exhalation. 1200 800
Residual Volume (RV): The amount of air remaining in the lungs after a forced exhalation. 1200 1000
Lung Capacity Measurements    
Vital capacity (VC): VC = IRV + VT + ERV. The volume of air that can be exhaled after a maximal inspiration. 4800 3200
Inspiratory capacity (IC): IC = VT + IRV. The volume of air that can be inhaled after a normal exhalation. 3600 2400
Functional residual capacity (FRC): FRC = ERV + RV. The lung volume at rest after a normal tidal volume exhalation. 2400 1800
Total lung capacity (TLC): TLC = IC + ERV + RV. The maximal amount of air that the lungs can accommodate. 6000 4200
Residual volume/total lung capacity ratio (RV/TLC × 100): The percentage of TLC occupied by the RV. image image

image

Restrictive Lung Disorders: Lung Volume and Capacity Findings

Table 3-2 presents an overview of the lung volume and capacity findings characteristic of restrictive lung disorders. Restrictive lung volumes and capacities are associated with pathologic conditions that alter the anatomic structures of the lungs distal to the terminal bronchioles (i.e., the alveoli or the lung parenchyma). Table 3-3 provides some of the more common restrictive anatomic alterations of the lungs and examples of respiratory disorders that cause them. Restrictive lung disorders result in an increased lung rigidity, which in turn decreases lung compliance. When lung compliance decreases, the ventilatory rate increases and the tidal volume (VT) decreases (see Figure 2-23).

Table 3-2

Restrictive Lung Disorders: Lung Volume and Capacity Findings

VT
N or ↓
IRV
ERV
RV
 
VC
IC
FRC
TLC
RV/TLC
N

image

N, Normal.

Table 3-3

Anatomic Alterations of the Lungs Associated with Restrictive Lung Disorders: (Pathology of the Alveoli or Lung Parenchyma)

Pathology (Anatomic Alteration of the Alveoli) Examples of Respiratory Disorders Associated with Specific Pathology
Atelectasis Pneumothorax, pleural effusion, flail chest, or mucous plugging
Consolidation Pneumonia, acute respiratory distress syndrome, lung abscess, tuberculosis
Increased alveolar-capillary membrane thickness Pulmonary edema, pneumoconiosis, tuberculosis, fungal disease

Obstructive Lung Disorders: Lung Volume and Capacity Findings

Table 3-4 provides an overview of the lung volumes and capacity findings characteristic of obstructive lung disorders. These lung volume and capacity findings are associated with pathologic conditions that alter the tracheobronchial tree. Table 3-5 provides some of the more common obstructive anatomic alterations of the lungs and examples of respiratory disorders that cause them.

Table 3-4

Obstructive Lung Disorders: (Lung Volume and Capacity Findings)

VT
N or ↑
IRV
N or ↓
ERV
N or ↓
RV
 
VC
IC
N or ↓
FRC
TLC
N or ↑
RV/TLC ratio
N or ↑

image

N, Normal.

Table 3-5

Anatomic Alterations of the Lungs Associated with Obstructive Lung Disorders: (Pathology of the Tracheobronchial Tree)

Pathology (Anatomic Alteration of the Bronchial Airways) Examples of Respiratory Disorders Associated with Specific Pathology
Excessive mucous production and accumulation Chronic bronchitis, asthma, respiratory syncytial virus
Bronchospasm Asthma
Distal airway weakening Emphysema

In obstructive lung disorders, the gas that enters the alveoli during inspiration (when the bronchial airways are naturally wider) is prevented from leaving the alveoli during expiration (when the bronchial airways narrow). As a result, the alveoli become overdistended with gas, a condition known as air trapping. Figure 3-1 provides a visual comparison of obstructive and restrictive lung disorders.

Forced Expiratory Flow Rate and Volume Measurements

In addition to the volumes and capacities that can be measured by pulmonary function testing, the flow rate and volume at which gas flows out of the lungs also can be measured. Such measurements provide data on the patency of the airways and the severity of the airway impairment.

Forced Vital Capacity

The forced vital capacity (FVC) is the total volume of gas that can be exhaled as forcefully and rapidly as possible after a maximal inspiration. In the healthy individual, the total expiratory time (TET) necessary to perform a FVC is 4 to 6 seconds. In obstructive lung disease (e.g., chronic bronchitis or emphysema), the TET increases because of the increased airway resistance and air trapping associated with the disorder. TETs of more than 10 seconds have been reported in these patients. In the normal individual the FVC equals the vital capacity (VC). Clinically, the lungs are considered normal if the FVC and the VC are within 200 mL of each other. In the patient with obstructive lung disease the FVC is lower than the VC because of increased airway resistance and air trapping with maximal effort (Figure 3-2).

A decreased FVC also is a common clinical manifestation in the patient with a restrictive lung disorder (e.g., pneumonia, acute respiratory distress syndrome, atelectasis). This decrease is mainly a result of the fact that restrictive lung disorders reduce the patient’s ability to fully expand the lungs, thus reducing the VC necessary to generate a good FVC exhalation. However, the TET required to perform an FVC exhalation is usually normal or even less than normal because of the high lung elasticity (low lung compliance) associated with restrictive disorders.

A number of pulmonary function tests can be extrapolated from a single FVC maneuver. The most common tests are as follows:

Forced Expiratory Volume Timed

The maximum volume of gas that can be exhaled over a specific period is the forced expiratory volume timed (FEVT). This measurement is obtained from an FVC measurement. Commonly used time periods are 0.5, 1.0, 2.0, 3.0, and 6.0 seconds. The most commonly used time period is 1 second (forced expiratory volume in 1 second [FEV1]). In the normal adult the percentages of the total volume exhaled during these time periods are as follows: FEV0.5, 60%; FEV1, 83%; FEV2, 94%; and FEV3, 97%. In obstructive disease the FEVT is decreased because the time necessary to exhale a certain volume forcefully is increased (Figure 3-3). Although the FEVT may be normal in restrictive lung disorders (e.g., pneumonia, acute respiratory distress syndrome, atelectasis), it is commonly decreased because of the decreased VC associated with restrictive disorders (similar to the FVC in restrictive disorders). The FEVT progressively decreases with age.

Forced Expiratory Volume in 1 second/Forced Vital Capacity (FEV1/FVC) Ratio

The FEV1/FVC ratio compares the amount of air exhaled in 1 second with the total amount exhaled during an FVC maneuver. Because the FEV1/FVC ratio is expressed as a percentage, it is commonly referred to as the forced expiratory volume in 1 second percentage (FEV1%). Simply stated, the FEV1/FVC ratio provides the percentage of the patient’s total volume of air forcefully exhaled (FVC) in 1 second. As discussed earlier in the FEVT section, the normal adult exhales 83% or more of the FVC in 1 second (FEV1). Therefore the FEV1/FVC ratio should also be 83% or greater under normal circumstances. The FEV1% progressively decreases with age.

Clinically, the FVC, FEV1, and FEV1% are commonly used to (1) assess the severity of a patient’s pulmonary disorder and (2) to determine whether the patient has either an obstructive or a restrictive lung disorder. The primary pulmonary function study differences between an obstructive and a restrictive lung disorder are as follows:

Forced Expiratory Flow 25%-75% (FEF25%-75%)

The FEF25%-75% is the average flow rate generated by the patient during the middle 50% of an FVC measurement (Figure 3-4). This expiratory maneuver is used to evaluate the status of medium-to-small airways in obstructive lung disorders. The normal FEF25%-75% in a healthy man 20 to 30 years of age is about 4.5 L/sec (270 L/min). The normal FEF25%-75% in a healthy woman 20 to 30 years of age is about 3.5 L/sec (210 L/min). The FEF25%-75% is somewhat effort-dependent because it depends on the FVC exhaled.

The FEF25%-75% progressively decreases in obstructive diseases and with age. The FEF25%-75% may also be decreased in moderate or severe restrictive lung disorders. This decrease is believed to be caused primarily by the reduced cross-sectional area of the small airways associated with restrictive lung problems. Clinically, the FEF25%-75% is often used to further confirm—or rule out—the presence of an obstructive pulmonary disease in the patient with a borderline FEV1% value.

Forced Expiratory Flow 200-1200 (FEF200-1200)

The FEF200-1200 measures the average flow rate between 200 and 1200 mL of an FVC (Figure 3-5). The first 200 mL of the FVC is usually exhaled more slowly than at the average flow rate because of (1) the normal inertia involved in the respiratory maneuver and (2) the initial slow response time of the pulmonary function equipment. Because the FEF200-1200 measures expiratory flows at high lung volumes (i.e., the initial part of the FVC), it provides a good assessment of the large upper airways. The FEF200-1200 is relatively effort-dependent.

The normal FEF200-1200 for the average healthy man 20 to 30 years of age is approximately 8 L/sec (480 L/min). The normal FEF200-1200 in the average healthy woman 20 to 30 years of age is approximately 5.5 L/sec (330 L/min). The FEF200-1200 decreases in obstructive lung disorders. The FEF200-1200 is a good test to determine the patient’s response to bronchodilator therapy. In restrictive lung disorders the FEF200-1200 is usually normal because it measures the early expiratory flow rates during the first part of an FVC maneuver (i.e., when the patient’s VC is at its highest level). The FEF200-1200 progressively decreases with age.

Peak Expiratory Flow Rate (PEFR)

The PEFR (also known as the peak flow rate) is the maximum flow rate generated during an FVC maneuver (Figure 3-6). The PEFR provides a good assessment of the large upper airways. It is quite effort-dependent. The normal PEFR in the average healthy man 20 to 30 years of age is approximately 10 L/sec (600 L/min). The normal PEFR in the average healthy woman 20 to 30 years of age is approximately 7.5 L/sec (450 L/min). The PEFR decreases in obstructive lung diseases. In restrictive lung disorders, the PEFR is usually normal because it measures the early expiratory flow rates during the first part of an FVC maneuver (i.e., when the patient’s VC is at its highest level). The PEFR progressively decreases with age.

The PEFR also can easily be measured at the patient’s bedside with a hand-held peak flowmeter (e.g., Wright peak flowmeter). The hand-held peak flowmeter is used to monitor the degree of airway obstruction on a moment-to-moment basis and is relatively small, inexpensive, accurate, reproducible, and easy for the patient to use. In addition, the mouthpieces are disposable, thus allowing the safe use of the same peak flowmeter from one patient to another. PEFR measurements should routinely be performed at the patient’s bedside to assess the degree of bronchospasm, effect of bronchodilators, and day-to-day progress. The PEFR results generated by the patient before and after bronchodilator therapy can serve as excellent objective data by which to assess the effectiveness of therapy.

Maximum Voluntary Ventilation (MVV)

The MVV is the largest volume of gas that can be breathed voluntarily in and out of the lungs in 1 minute (Figure 3-7). The normal MVV in the average healthy man 20 to 30 years of age is approximately 170 L/min. The normal MVV in the average healthy woman 20 to 30 years of age is approximately 110 L/min. The MVV progressively decreases in obstructive pulmonary disorders. In restrictive pulmonary disorders, the MVV may be normal or decreased.

Flow-Volume Loop

The flow-volume loop is a graphic illustration of both a forced vital capacity (FVC) maneuver and a forced inspiratory volume (FIV) maneuver. The FVC and FIV are plotted together as two curves that form what is called a flow-volume loop. As shown in Figure 3-8, the upper half of the flow-volume loop (above the zero flow axis) represents the maximum expiratory flow generated at various lung volumes during an FVC maneuver plotted against volume. This portion of the curve shows the flow generated between the TLC and RV.

image
FIGURE 3-8 Flow-volume loop.

The lower half of the flow-volume loop (below the zero flow axis) illustrates the maximum inspiratory flow generated at various lung volumes during a forced inspiration (called a forced inspiratory volume [FIV]) plotted against the volume inhaled. This portion of the curve shows the flow generated between the RV and TLC. Depending on the sophistication of the equipment, several important pulmonary function study measurements can be obtained, including the following:

In the normal subject the expiratory flow rate decreases linearly during an FVC maneuver, immediately after the PEFR has been achieved. In the patient with an obstructive lung disease, however, the flow rate decreases in a nonlinear fashion after the PEFR has been reached. This nonlinear flow rate causes a cuplike or scooped-out appearance in the expiratory flow curve when 50% of the FVC has been exhaled. This portion of the flow curve is the FEF50%, or (Figure 3-9). Table 3-6 summarizes (1) the forced expiratory flow rate and volume measurements and (2) the normal values found in healthy men and women ages 20 to 30 years.

Table 3-6

Normal Forced Expiratory Flow Rate Measurements in Healthy Men and Women 20 to 30 Years of Age

Forced Expiratory Flow Rate Measurement Men Women
image
Forced vital capacity (FVC). A is the point of maximal inspiration and the starting point of an FVC maneuver. Note the reduction in FVC in obstructive pulmonary disease, caused by dynamic compression of the airways.
Usually equals vital capacity (VC) (FVC and VC should be within 200 mL of each other) Usually equals VC (FVC and VC should be within 200 mL of each other)
image
Forced expiratory volume timed (FEVT): FEV0.5, FEV1.0, FEV2.0, FEV3.0. In obstructive disorders, more time is needed to exhale a specified volume.

Forced expiratory volume in 1 second/forced vital capacity ratio (FEV1/FVC); commonly called forced expiratory volume in 1 second percentage (FEV1%). Derived by dividing the predicted FEV1 by the predicted FVC
Should be > 70% Derived by dividing the predicted FEV1 by the predicted FVC
Should be > 70% image
Forced expiratory flow 25%-75% (FEF25%-75%). This test measures the average rate of flow between 25% and 75% of an FVC maneuver. The flow rate is measured when 25% of the FVC has been exhaled and again when 75% of the FVC has been exhaled. The average rate of flow is derived by dividing the combined flow rates by 2. 4.5 L/sec (270 L/min) 3.5 L/sec (210 L/min) image
Forced expiratory flow 200-1200 (FEF200-1200). This test measures the average rate of flow between 200 mL and 1200 mL of an FVC maneuver. The flow rate is measured when 200 mL have been exhaled and again when 1200 mL have been exhaled. The average rate of flow is derived by dividing the combined flow rates by 2. 8 L/sec (480 L/min) 5.5 L/sec (330 L/min) image
Peak expiratory flow rate (PEFR). The maximum flow rate (steepest slope of the volume-time trace) generated during an FVC maneuver. 8-10 L/sec (500-600 L/min) 7.5 L/sec (450 L/min) image
Maximum voluntary ventilation (MVV). The largest volume of gas that can be breathed voluntarily in and out of the lungs in 1 minute. 170 L/min 110 L/min

image

image

Table 3-7 provides an overview of the expiratory flow rate measurements characteristic of restrictive lung disorders. In restrictive lung disorders, flow and volume are, in general, reduced equally. Clinically, this phenomenon is referred to as symmetric reduction in flows and volumes. The flow-volume loop therefore is a small version of normal in restrictive pulmonary disease (Figure 3-10).

Table 3-7

Restrictive Lung Disease: Forced Expiratory Flow Rate and Volume Findings

FVC
FEVT
N or ↓
FEV1/FVC
N or ↑
FEF25%-75%
N or ↓
FEF50%
N or ↓
FEF200-1200
N or ↓
PEFR
N or ↓
MVV
N or ↓

image

Table 3-8 provides an overview of the expiratory flow rate measurements characteristic of obstructive lung disorders. Obstructive lung disorders cause increased airway resistance (Raw) and airway closure during expiration. When Raw becomes high, the patient’s ventilatory rate decreases and the VT increases. This ventilatory pattern is thought to be an adaptation to reduce the work of breathing (see Figure 2-23).

Table 3-8

Obstructive Lung Diseases: Forced Expiratory Flow Rate and Volume Findings

FVC
FEVT
FEV1/FVC
FEF25%-75%
FEF50%
FEF200-1200
PEFR
MVV

image

Pulmonary Diffusion Capacity

The pulmonary diffusion capacity of carbon monoxide (Dlco) measures the amount of carbon monoxide (CO) that moves across the alveolar-capillary membrane. When the patient has a normal hemoglobin concentration, pulmonary capillary blood volume, and ventilatory status, the only limiting factor to the diffusion of CO is the alveolar-capillary membrane. Under normal conditions the average Dlco value for the resting man is 25 mL/min/mm Hg (STPD). This value is slightly lower in women, presumably because of their smaller normal lung volumes. Table 3-9 provides a general guide to conditions that alter the patient’s Dlco.